Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Allergen or component thereof
Reexamination Certificate
2005-06-28
2005-06-28
Smith, L. J. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Allergen or component thereof
C424S184100, C424S185100, C424S191100, C424S265100, C424S276100, C530S300000, C530S350000, C435S069100, C435S069700
Reexamination Certificate
active
06911208
ABSTRACT:
A substantially pure, isolated, antigenic protein from fungi of the genusMalassezia, characterized in that said antigenic protein has a binding ability to IgE antibodies from patients with allergies; an antigenic fragment derived from the antigenic protein; and an antibody against the antigenic protein or fragments thereof. According to the present invention, there can be provided an isolated and purified antigenic protein having high purity fromMalassezia, antigenic fragments thereof, and a specific antibody against those antigenic protein or fragments thereof. In addition, there can be provided a diagnostic agent, a therapeutic agent, or a prophylactic drug forMalasseziaallergies, wherein the agent includes, as an active ingredient, the antigenic protein or fragments thereof.
REFERENCES:
Sentandreu et al., “Cloning of cDNA coding forCandida albicanscell . . . ”Journal of Medical&Veterinary Mycology, vol. 33, No. 2, 1995, pp. 105-111, XP001022554.
Lindblom et al., “Cloning and sequencing of the cDNA encoding thePityrosporum. . . ”Journal of Allergy and Clinical Immunology, vol. 97, No. 1 part 3, 1996, p. 374 XP001034009.
Yasueda et al., “Identification and cloning of two novel allergens from the lipophilic yeast . . . ”Biochemical and Biophysical Research Communications, vol. 248, No. 2, Jul. 20, 1998, pp. 240-244, XP002184076.
Moser et al., “Cloning and Expression of Recombinant Asperigillus”Journal ofImmunology, vol. 149, No. 2, (1992) p. 454-460.
Johansson et al., “IgE-binding Components inPityrosporum orbiculare. . . ”Acta Derm Venereol(Stockh) vol. 71, 1991, pp. 11-16.
Zargari et al., “Identification of Allergen Components . . . ”,Allergy, 1994, vol. 49, pp. 50-56.
Jansen-Jarollim et al., “Atopic dermatitis of the face . . . ”,J. Allergy Clin. Immunolo., vol. 89, No. 1, 1992, pp. 44-51.
Arrunda et al., “Aspergillus fumigatusAllergenI . . . ”,J. Exp. Med., vol. 172, No. 5, 1990, pp. 1529-1532.
Garrard et al., “Two Genes Encode the Major Membrane . . . ”,J. Biol. Chem.vol. 264, No. 23, 1989, pp. 13929-13937.
Matsumoto et al., “Iron- and Maganese-Containing Superoxide . . . ”,Biochemistry, vol. 30, No. 13, 1991, pp. 3210-3216.
Ludwig et al., “Maganese Superoxide Dismutase . . . ”,J. Mol. Biol., vol. 219, No. 2, 1991, pp. 335-358.
Savolainen et al., “Crossreacting IgE Antibodies toPityrosporum. . . ”,Clinical and Experimental Allergy, vol. 22, 1992, pp. 469-474.
Rudinger et a., “Characteristics of the Amino Acids as Components . . . ”,Peptide Hormones, Edited by Parsons, University Park Press, Baltimore, 1976.
M. Carmen Menendez et al., “Cloning and expression ofMycobacterium fortuitumsuperoxide dismutase gene”, FEMS Microbiology Letters, vol. 134, No. 2-3, (1995), pp. 273-278. XP-001063033.
R.A. Hallewell et al., “Sequence of a CDNA Coding For Mouse Manganese Superoxide Dismutase”, Nucleic Acids Research, vol. 14, No. 23, (Dec. 9, 1986), p. 9539. XP-001057377.
Akiyama Kazuo
Kato Ikunoshin
Kuroda Masanobu
Okado Takashi
Onishi Yoshimi
Baskar Padma
Smith L. J.
Takara Bio Inc.
LandOfFree
Antigenic protein originating in malassezia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antigenic protein originating in malassezia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic protein originating in malassezia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3512026